Skip to main content

Table 1 Baseline and ongoing data collection

From: The Lipid lowering and Onset of Renal Disease (LORD) Trial: A randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progression of kidney disease

Baseline data and follow-up data every three months for 36 months

eGFR Cockcroft and Gault

eGFR MDRD

24 hour urine creatinine clearance

24 hour urine protein

Weight and blood pressure

Adverse events and concomitant therapy

Laboratory tests

   Hematology

   Biochemistry

   Oxidative stress measures

   Inflammation measures

   Lipid profile

Baseline data and follow-up data at 9,18,27 and 36 months

SF 36

Active Australia Questionnaire

Four-day diet diary